Relationship Between Clinical Efficacy on Asthma Treated by Scarring Moxibustion and Fester Capacity

Objective To investigate the relationship between fester capacity and clinical efficacy on allergic asthma treated by scarring moxibustion. Methods The patients were randomly divided into scarring moxibustion 9-cone group, 3-cone group and 6-cone group. The biggest area, scab-lost time, first-festering time and scarring time of moxibustion sore, and the clinical efficacy in each group was observed. Results The biggest post-moxibustion sore area in 9-cone group was larger than that in 3-cone group, but had no difference in comparison with 6-cone group; the scab-lost time, first-festering time and scarring time of post-moxibustion sore in each group were of no difference. The clinical efficacy was better in 9-cone group than in 3-cone group, but had no difference in comparison with the 6-cone group. Conclusion Fester capacity in treating allergic asthma by scarring moxibustion is related to the clinical efficacy and definite fester capacity is the key to good results on allergic asthma.